1Gurbel PA, Bliden KP, Guyer K, et al. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study [ J ]. J Am Coil Cardiol, 2005,46 ( 10 ) : 1820 - 1826. 被引量：1
2Guthikonda S, Lev EI, Kleiman NS. Resistance to antiplatelet therapy[ J]. Curr Cardiol Rep ,2005,7 (4) :242 - 248. 被引量：1
3Gurbel PA, Bliden KP, Guyer K, et al. Platelet reactivity in patients and recurrent events post-stenting [ J ]. Journal of American College of Cardiology ,2005,46 ( 10 ) : 1820 - 1826. 被引量：1
4Bliden KP, DiChiara J, Tantry US, et al. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention:is the current antiplatelet therapy adequate? [ J]. J Am Coil Cardiol,2007,49(6) : 657 - 666. 被引量：1
3Michelle M. Graham Outcomes of aider-hours versus regular working hours primary percutaneous coronary intervention for acute myocar- dial infarction [J]. BMJ Qual Saf Health Care, 2011,20(1): 60-67. 被引量：1
4Aronow HD. Bleeding risk associated with lyear of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial [J]. Am Heart J, 2009,157(2):369-374. 被引量：1
5Smith S C Jr,Feldman T E,Hirshfeld J W Jr,Jacobs AK,Kern M J,King S B 3rd,et al. ACC/AHA/SCAI.2005 guideline update for percutaneous coronary inter-vention:a report of the American College of Cardiolo-gy/American Heart Association Task Force On PracticeGuidelines (ACC/ AH A/ SC AI Writing Committee toupdate the 2001 guidelines for pereutmmous coronaryintervention)[J],J Am Coll Cardiol,2006 ,47 :el-el21. 被引量：1
6Tolleson T R,Newby L K,Harrington R A,Bhapkar MV,Verheugt F W,Berger P B,et al. Frequency of stentthrombosis after acute coronary syndromes (from theSYMPHONY and 2nd SYMPHONY trials)[J].Am JCardiol,2003,92 :330-333. 被引量：1
7Fifi J T,Brockington C,Narang J,Leesch W,Ewing SL,Bennet H,et al. Clopidogrel resistance is associatedwith thromboembolic complications in patients undergo-ing neurovascular stenting[J].AJNR Am J Neuroradi-ol,2013 ,34 :716-720. 被引量：1
8Simon T,Verstuyft C,Mary-Krause M,Quteineh L,Drouet E,Meneveau N,et al. Genetic determinants ofresponse to clopidogrel and cardiovascular events [J].NEngl J Med,2009,360:363-375. 被引量：1
9Mega J L,Close S L,Wiviott S D,Shen L,Hockett RD,Brandt J T,et al. Cytochrome p-450 polymorphismsand response to clopidogrel[J].N Engl J Med,2009 ,360:354-362. 被引量：1
10Hobson A R,Petley G W,Dawkins K D,Curzen N. Anovel fifteen minute test for assessment of individualtime-dependent clotting responses to aspirin and clopi-dogrel using modified thrombelastography [ J]. Plate-lets,2007 ,18 :497-505. 被引量：1
